Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.13% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GGRP
3076
Glimpse Group
GGRP
$21.2M
| $69.1K | ﹤0.01% |
133,897
-21,053
| -14% | -$16.5K |
|
|
INN
3077
Summit Hotel Properties
INN
$761M
| $68.5K | ﹤0.01% |
+15,500
| New | +$69.5K |
|
3078
CXApp
CXAI
$13.6M
| $67.1K | ﹤0.01% |
371,754
+263,154
| +242% | +$65.4K |
|
3079
Dyadic International
DYAI
$47.4M
| $67K | ﹤0.01% |
81,665
-65,950
| -45% | -$55.4K |
|
3080
Neonode
NEON
$13.8M
| $66.8K | ﹤0.01% |
+47,703
| New | +$82.5K |
|
3081
Estrella Immunopharma
ESLA
$32.7M
| $66.6K | ﹤0.01% |
62,795
-59,673
| -49% | -$68.6K |
|
|
ELWT
3082
Elauwit Connection Inc
ELWT
$45.5M
| $66.4K | ﹤0.01% |
+11,200
| New | +$67.8K |
|
3083
Pluri
PLUR
$20M
| $65.9K | ﹤0.01% |
19,424
-600
| -3% | -$2.01K |
|
3084
Skillful Craftsman
EDTK
$15.1M
| $63.4K | ﹤0.01% |
62,800
-9,500
| -13% | -$9.11K |
|
3085
Moving iMage Technologies
MITQ
$5.37M
| $63.4K | ﹤0.01% |
122,400
+5,100
| +4% | +$3.3K |
|
|
IPM
3086
Intelligent Protection Management Corp
IPM
$23.5M
| $63.2K | ﹤0.01% |
41,300
-13,800
| -25% | -$23.9K |
|
3087
Research Frontiers
REFR
$16.9M
| $62.8K | ﹤0.01% |
68,300
-9,982
| -13% | -$10.9K |
|
3088
Candel Therapeutics
CADL
$739M
| $62.6K | ﹤0.01% |
+12,780
| New | +$69.5K |
|
3089
Beamr Imaging
BMR
$18.9M
| $62.5K | ﹤0.01% |
45,000
+3,300
| +8% | +$5.84K |
|
3090
Arena Group
AREN
$48.1M
| $62.3K | ﹤0.01% |
28,700
+2,500
| +10% | +$8.32K |
|
|
ASPSZ
3091
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$11.2M
| $61.6K | ﹤0.01% |
307,803
-26,900
| -8% | -$6.9K |
|
|
FFWM
3092
DELISTED
First Foundation Inc
FFWM
| $61.4K | ﹤0.01% |
10,400
-94,400
| -90% | -$573K |
|
3093
National CineMedia
NCMI
$358M
| $59.2K | ﹤0.01% |
+19,400
| New | +$68.1K |
|
|
NOTV
3094
DELISTED
Inotiv
NOTV
| $58.6K | ﹤0.01% |
214,864
-123,936
| -37% | -$51K |
|
|
VIVO
3095
VivoPower PLC
VIVO
$120M
| $58.4K | ﹤0.01% |
25,400
-109,658
| -81% | -$245K |
|
|
ARAI
3096
Arrive AI Inc
ARAI
$15.9M
| $58.3K | ﹤0.01% |
+73,100
| New | +$116K |
|
3097
Nerdy
NRDY
$105M
| $58K | ﹤0.01% |
71,000
+2,300
| +3% | +$2.21K |
|
3098
Braskem
BAK
$968M
| $57.1K | ﹤0.01% |
15,600
-249,888
| -94% | -$946K |
|
3099
Cytosorbents Corp
CTSO
$24M
| $57K | ﹤0.01% |
100,720
+600
| +0.6% | +$410 |
|
3100
Bionano Genomics
BNGO
$12.9M
| $57K | ﹤0.01% |
48,700
+11,700
| +32% | +$15K |
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.